BioCentury | Oct 28, 2020
Product Development

Data Byte: FOLR1 pipeline for cancer

...IMGN853) MORAb-202 STRO-002 TPIV200 (TPIV 200, TPIV200/huFR-1) Folate receptor alpha peptide vaccine ImmunoGen Inc. Eisai Co. Ltd. Epsilogen Ltd. Sutro Biopharma Inc. Marker Therapeutics Inc. Mayo Clinic Huadong...
BioCentury | Oct 28, 2020
Deals

Thrive takeout could herald consolidation trend for early cancer detection companies

...also brings a partnership with Johns Hopkins University, while Exact Sciences is partnered with the Mayo Clinic.Thrive...
BioCentury | Oct 24, 2020
Translation in Brief

UNC Chapel Hill Angelman gene therapy rescues motor function; plus data backing planned Pacylex, Kronos clinical trials and more

...inhibitor in advanced solid tumors.CSF, plasma biomarker for spinocerebellar ataxia type 3A team led by Mayo Clinic...
...of North Carolina at Chapel Hill Asklepios BioPharmaceutical Inc. Pacylex Pharmaceuticals University of Alberta Kronos Bio Inc. Massachusetts Institute of Technology Mayo Clinic University...
BioCentury | Sep 29, 2020
Distillery Therapeutics

Repeat expansion-targeting antisense oligo for ALS and frontotemporal dementia

...Medicine, University of Pennsylvania, Philadelphia, Pa.email: jshorter@pennmedicine.upenn.eduCONTACT: Leonard Petrucelli, Mayo Clinic...
...same affiliation as aboveemail: zhang.yongjie@mayo.edu Claire Quang University of Pennsylvania Mayo Clinic Chromosome...
BioCentury | Sep 25, 2020
Finance

Sept. 24 Quick Takes: AveXis vets steer Taysha to IPO; plus Exact Sciences, Monte Rosa, OBiO, Moderna, Immetas and more

...Chairman, President and CEO Kevin Conroy revealed early data from the company’s collaboration with the Mayo Clinic...
BioCentury | Sep 2, 2020
Regulation

NIH: ‘Plasma should not be considered standard of care’

...an expanded use program run by the Mayo Clinic...
BioCentury | Sep 2, 2020
Product Development

COVID-19 Quick Takes: NAS framework on vaccine allocation prioritizes higher risk groups

...benefit for Humanigen mAbMayo Clinic researchers have reported in Mayo Clinic...
...sarilumab (Generic) lenzilumab (KB003) AstraZeneca plc Entos Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc. Sanofi Mayo Clinic Humanigen...
BioCentury | Aug 24, 2020
Regulation

Ex-FDA officials: EUA may be merited, but FDA put politics ahead of science

...uncontrolled study.” Steve Usdin U.S. Food and Drug Administration (FDA) Mayo Clinic convalescent...
BioCentury | Aug 18, 2020
Product Development

Unity outlines path forward for anti-aging programs after Phase II osteoarthritis failure

...in Science by company co-founders Jan van Deursen and Judith Campisi and colleagues from the Mayo Clinic. At...
BioCentury | Jul 14, 2020
Product Development

Warp Speed accelerating mAbs, bullish on convalescent plasma for COVID-19

...access program sponsored by Biomedical Advanced Research and Development Authority (BARDA) and run by the Mayo Clinic...
Items per page:
1 - 10 of 472
BioCentury | Oct 28, 2020
Product Development

Data Byte: FOLR1 pipeline for cancer

...IMGN853) MORAb-202 STRO-002 TPIV200 (TPIV 200, TPIV200/huFR-1) Folate receptor alpha peptide vaccine ImmunoGen Inc. Eisai Co. Ltd. Epsilogen Ltd. Sutro Biopharma Inc. Marker Therapeutics Inc. Mayo Clinic Huadong...
BioCentury | Oct 28, 2020
Deals

Thrive takeout could herald consolidation trend for early cancer detection companies

...also brings a partnership with Johns Hopkins University, while Exact Sciences is partnered with the Mayo Clinic.Thrive...
BioCentury | Oct 24, 2020
Translation in Brief

UNC Chapel Hill Angelman gene therapy rescues motor function; plus data backing planned Pacylex, Kronos clinical trials and more

...inhibitor in advanced solid tumors.CSF, plasma biomarker for spinocerebellar ataxia type 3A team led by Mayo Clinic...
...of North Carolina at Chapel Hill Asklepios BioPharmaceutical Inc. Pacylex Pharmaceuticals University of Alberta Kronos Bio Inc. Massachusetts Institute of Technology Mayo Clinic University...
BioCentury | Sep 29, 2020
Distillery Therapeutics

Repeat expansion-targeting antisense oligo for ALS and frontotemporal dementia

...Medicine, University of Pennsylvania, Philadelphia, Pa.email: jshorter@pennmedicine.upenn.eduCONTACT: Leonard Petrucelli, Mayo Clinic...
...same affiliation as aboveemail: zhang.yongjie@mayo.edu Claire Quang University of Pennsylvania Mayo Clinic Chromosome...
BioCentury | Sep 25, 2020
Finance

Sept. 24 Quick Takes: AveXis vets steer Taysha to IPO; plus Exact Sciences, Monte Rosa, OBiO, Moderna, Immetas and more

...Chairman, President and CEO Kevin Conroy revealed early data from the company’s collaboration with the Mayo Clinic...
BioCentury | Sep 2, 2020
Regulation

NIH: ‘Plasma should not be considered standard of care’

...an expanded use program run by the Mayo Clinic...
BioCentury | Sep 2, 2020
Product Development

COVID-19 Quick Takes: NAS framework on vaccine allocation prioritizes higher risk groups

...benefit for Humanigen mAbMayo Clinic researchers have reported in Mayo Clinic...
...sarilumab (Generic) lenzilumab (KB003) AstraZeneca plc Entos Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc. Sanofi Mayo Clinic Humanigen...
BioCentury | Aug 24, 2020
Regulation

Ex-FDA officials: EUA may be merited, but FDA put politics ahead of science

...uncontrolled study.” Steve Usdin U.S. Food and Drug Administration (FDA) Mayo Clinic convalescent...
BioCentury | Aug 18, 2020
Product Development

Unity outlines path forward for anti-aging programs after Phase II osteoarthritis failure

...in Science by company co-founders Jan van Deursen and Judith Campisi and colleagues from the Mayo Clinic. At...
BioCentury | Jul 14, 2020
Product Development

Warp Speed accelerating mAbs, bullish on convalescent plasma for COVID-19

...access program sponsored by Biomedical Advanced Research and Development Authority (BARDA) and run by the Mayo Clinic...
Items per page:
1 - 10 of 472